Support WBURFDA Challenges Stem Cell Companies As Patients Run Out Of TimePlay11:30Download AudioNPR StaffFebruary 02, 2013 ShareScientists have seen promise in the potential of stem cells, but not everyone agrees stem cell replacement therapy is ready for prime time. (U.S. Food and Drug Administration)
